Back to WELLINGTON MANAGEMENT GROUP LLP

APGE
Showing 8 of 10 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLP's holdings in APOGEE THERAPEUTICS INC

WELLINGTON MANAGEMENT GROUP LLP holds 4.4M shares of APGE (APOGEE THERAPEUTICS INC), worth $368.3M as of 2026-Q1. The position was decreased (-7.8% shares). APGE represents 0.1% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$368.3M

Current Shares

4.4M

Total Value Change

+$228.7M

Total Shares Change

+828,754

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
4.4M
-7.8%
$368.3M0.1%$68.50
0
2025-Q4
Increased
4.7M
+0.5%
$358.3M0.1%$75.76
31
2025-Q3
Increased
4.7M
+24.1%
$187.7M0.0%$39.83
37
2025-Q2
Decreased
3.8M
-30.6%
$165.3M0.0%$43.38
0
2025-Q1
Increased
5.5M
+21.4%
$204.9M0.0%$39.72
37
2024-Q4
Decreased
4.5M
-6.2%
$204.6M0.0%$44.64
0
2024-Q3
Increased
4.8M
+35.7%
$282.8M0.0%$57.99
40
2024-Q2
Increased
3.5M
+56.3%
$139.6M0.0%$39.35
43

Other major holders of APGE: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used